AL JABAL DRUGS & MEDICAL APPLIANCES — Ceftriaxone Importer Profile
Pharmaceutical Importer · #8 buyer for Ceftriaxone · $5.2M import value · 232 shipments · YEMEN, DEMOCRATIC · DGFT Verified
AL JABAL DRUGS & MEDICAL APPLIANCES is the #8 importer of Ceftriaxone from India with $5.2M in import value and 232 verified shipments. AL JABAL DRUGS & MEDICAL APPLIANCES holds a 1.3% market share in Ceftriaxone imports based in YEMEN, DEMOCRATIC. The company sources from 2 verified suppliers across 40 formulations shipped to 3 countries.
AL JABAL DRUGS & MEDICAL APPLIANCES — Ceftriaxone Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ceftriaxone to AL JABAL DRUGS & MEDICAL APPLIANCES?
Verified from 232 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $5.1M | 216 | 97.6% |
| AKUMS DRUGS AND PHARMACEUTICALS LIMITED | $125.2K | 16 | 2.4% |
AL JABAL DRUGS & MEDICAL APPLIANCES sources Ceftriaxone from 2 verified Indian suppliers based on 232 customs records. The primary supplier is CIPLA LIMITED accounting for 97.6% of imports.
How Does AL JABAL DRUGS & MEDICAL APPLIANCES Compare to Nearest Ceftriaxone Importers?
Buyers ranked immediately above and below #8 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | ROYAL PHARMA 2011 LIMITED | KENYA | $6.8M | 135 | $50.0K |
| 5 | AUROVIDA FARMACEUTICA, SA DE CV, | MEXICO | $4.8M | 96 | $50.0K |
| 8 | AL JABAL DRUGS & MEDICAL APPLIANCES ★ | YEMEN | $3.8M | 184 | $20.4K |
| 2 | SAAM GROUP LTD | PAKISTAN | $3.6M | 73 | $50.0K |
| 9 | TO THE DIRECTOR OF | SUDAN | $2.3M | 97 | $23.9K |
AL JABAL DRUGS & MEDICAL APPLIANCES ranks #8 among 2,555 Ceftriaxone importers from India. Average shipment value of $20.4K compared to the market average of $12.6K. The closest competitors by value are ROYAL PHARMA 2011 LIMITED and AUROVIDA FARMACEUTICA, SA DE CV,.
Where Does AL JABAL DRUGS & MEDICAL APPLIANCES Import Ceftriaxone To?
Destination countries from 232 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| YEMEN, DEMOCRATIC | $3.3M | 146 | 63.4% |
| YEMEN DEMOCRATIC | $1.2M | 63 | 23.3% |
| YEMEN | $692.2K | 23 | 13.3% |
AL JABAL DRUGS & MEDICAL APPLIANCES imports Ceftriaxone to 3 countries. The primary destination is YEMEN, DEMOCRATIC receiving 63.4% of shipments worth $3.3M.
What Ceftriaxone Formulations Does AL JABAL DRUGS & MEDICAL APPLIANCES Import?
| Formulation | Value | Shipments |
|---|---|---|
| CIPLACEF 1000 INJECTION 1GM (CEFTRIAXONESODIUM INJECTION POWDER 1000MG) | $1.2M | 43 |
| CIPLACEF 1000 INJECTION 1GM (CEFTRIAXONESODIUM INJECTION POWDER 1000MG)NOS | $668.7K | 54 |
| CIPLACEF 1000 INJECTION 1 GM (CEFTRIAXONE SODIUM INJECTION POWDER 1000 MG) . | $607.9K | 14 |
| CIPLACEF 500 INJECTION (CEFTRIAXONE SODI | $280.0K | 8 |
| CIPLACEF 1000 INJECTION 1 GM (CEFTRIAXONE SODIUM INJECTION POWDER 1000 MG)NOS | $210.9K | 12 |
| CIPLACEF 1000 INJECTION 1GM CEFTRIAXONE SODIUM INJECTION POWDER 1000MG 1 X 1 GM WFI | $207.6K | 7 |
| CIPLACEF 1000 INJECTION 1GM (CEFTRIAXONE SODIUM INJECTION POWDER 1000MG) 1 X 1 GM + WFI | $198.1K | 6 |
| CIPLACEF 1000 INJECTION 1 GM CEFTRIAXONE SODIUM INJECTION POWDER 1000 MG 1 X 1 GM WFI | $179.7K | 6 |
| CIPLACEF 1000 INJECTION 1 GM (CEFTRIAXONE SODIUM INJECTION POWDER 1000 MG) . | $156.5K | 9 |
| CIPLACEF 500 INJECTION (CEFTRIAXONE SODIUM INJECTION POWDER 500MG)NOS | $130.6K | 9 |
AL JABAL DRUGS & MEDICAL APPLIANCES imports 40 distinct Ceftriaxone formulations from India. The top formulation is CIPLACEF 1000 INJECTION 1GM (CEFTRIAXONESODIUM INJECTION POW with 43 shipments worth $1.2M.
Who Are the Top Buyers of Ceftriaxone from India and How Much Does AL JABAL DRUGS & MEDICAL APPLIANCES Import?
India exported $32.1M worth of Ceftriaxone through 11,257 shipments from 850 suppliers to 162 countries, serving 2,555 buyers globally. AL JABAL DRUGS & MEDICAL APPLIANCES imports $5.2M of this total, accounting for 1.3% of India's Ceftriaxone exports with 232 shipments from YEMEN, DEMOCRATIC. This is verified from 232 customs shipment records covering 40 distinct formulations.
What Is the Average Order Value for AL JABAL DRUGS & MEDICAL APPLIANCES's Ceftriaxone Imports?
AL JABAL DRUGS & MEDICAL APPLIANCES's average Ceftriaxone order value is $22.5K per consignment, based on 232 shipments totaling $5.2M. AL JABAL DRUGS & MEDICAL APPLIANCES is based in YEMEN, DEMOCRATIC and ranks #8 among all Ceftriaxone importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Ceftriaxone to AL JABAL DRUGS & MEDICAL APPLIANCES?
AL JABAL DRUGS & MEDICAL APPLIANCES sources Ceftriaxone from 2 verified Indian suppliers: CIPLA LIMITED ($5.1M, 97.6%), AKUMS DRUGS AND PHARMACEUTICALS LIMITED ($125.2K, 2.4%). This is based on 232 customs records.
How Does AL JABAL DRUGS & MEDICAL APPLIANCES Compare to Other Ceftriaxone Importers?
AL JABAL DRUGS & MEDICAL APPLIANCES ranks #8 among 2,555 Ceftriaxone importers from India with a 1.3% market share. The top 3 importers are ROYAL PHARMA 2011 LIMITED ($6.8M), AUROVIDA FARMACEUTICA, SA DE CV, ($4.8M), AL JABAL DRUGS & MEDICAL APPLIANCES ($3.8M). AL JABAL DRUGS & MEDICAL APPLIANCES processed 232 shipments from YEMEN, DEMOCRATIC.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ceftriaxone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ceftriaxone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: AL JABAL DRUGS & MEDICAL APPLIANCES matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as AL JABAL DRUGS & MEDICAL APPLIANCES's capped import value divided by total capped export value for Ceftriaxone across all Indian exporters.
- 5.Verified Records: This page is backed by 232 individual customs records matching AL JABAL DRUGS & MEDICAL APPLIANCES importing Ceftriaxone, covering 40 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 162+ countries, 2,555+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ceftriaxone Import Data for AL JABAL DRUGS & MEDICAL APPLIANCES
Access order-level details, pricing data, supplier connections, and competitive analysis for AL JABAL DRUGS & MEDICAL APPLIANCES's Ceftriaxone imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AL JABAL DRUGS & MEDICAL APPLIANCES
Company Profile
Multiple products · $0 total trade · Multiple categories
AL JABAL DRUGS & MEDICAL APPLIANCES × Ceftriaxone
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for AL JABAL DRUGS & MEDICAL APPLIANCES.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ceftriaxone. For current order-level data, contact TransData Nexus.